Curriculum Vitae
Professor Alireza Zali
Education:
(2nd rank of Medical School in Iran)
(2nd rank of Medical School in Iran)
(Thesis mark = 20 out of 20)
The 3rd place at Examination of promotion from 1 to 2 (1990).
The 1st place at Examination of promotion from 2 to 3 (1991)
The 1st place at Examination of promotion from 3 to 4 (1992).
The 1st place at Examination of promotion from 4 to 5 (1993).
The 1st place and the highest grade at National Board certificate examination (1994).
(2nd rank of Medical School in Iran)
(GPA: 17.64, Thesis mark = 19 out of 20)
Awards and Honors:
- Academic Experience:
v 2016-Present
v Position: Founder and President of
Shohada Tajrish Comprehensive Neurosurgical Center of Excellence (STNCE)
v Employer: Ministry of Health and Medical Education, Tehran, Iran
v 2008- Present
v Position: Founder and President of Functional Neurosurgery Research Center (FNRC)
v Employer: Shahid Beheshti University of Medical Sciences, Tehran, Iran
v 2006-Present
v Position: Chief of Iranian Medical Proteomics Association
v Employer: Ministry of Health and Medical Education, Tehran, Iran
v 2005-Present
v Position: Professor of the Department of Neurosurgery
v Employer: Shahid Beheshti University of Medical Sciences, Tehran, Iran
v 2001-2005
v Position: AssossiatedProfessor of the Department of Neurosurgery
v Employer: Shahid Beheshti University of Medical Sciences, Tehran, Iran
v 2000-Present
v Position: Head of Neurosurgery Ward
v Employer: Shohada
Tajrish Hospital, Tehran, Iran
v 1994-2001
v Position: AssistantProfessor of the Department of Neurosurgery
v Employer: Shahid Beheshti University of Medical Sciences, Tehran, Iran
v 1994-2001
v Position: Head of Neurosurgery Ward
v Employer: Mofid
Children's Hospital, Tehran, Iran
Patents:
4. Intranasal mask for COVID-19,
IR103293 . Issued Dec 27, 2020
5. Guide of Spinal Screw,
IR93230 . Issued Aug 16, 2017
6. Disposable cold light retractor to detect adequate vision of out-of-reach points in surgery,
IR84607 . Issued Dec 24, 2014
Publications (Citation: 2378; H-index: 25; i-10 index: 63)
https://scholar.google.com/citations?user=l0MZbkAAAAAJ&hl=en
- Books:
- Book Chapter:
1. Book: Multidisciplinarity and Interdisciplinarity in Health,
Edited by Nima Rezaei
O Chapter’s Title: Integrated, Multidisciplinary, and Interdisciplinary Medical Education
O Publication: Springer, Cham, August 2022
O DOI: 10.1007/978-3-030-96814-4_27
O Online ISBN978-3-030-96814-4
2. Book: Multidisciplinarity and Interdisciplinarity in Health,
Edited by Nima Rezaei
O Chapter’s Title:
Integrated Science 2050: Multidisciplinarity and Interdisciplinarity in Health
O Publication: Springer, Cham, August 2022
O DOI: 10.1007/978-3-030-96814-4_30
O Online ISBN978-3-030-96814-4
3. E-Book: Health Technologies and Innovations to Effectively Respond to the COVID-19 Pandemic, Edited by
Björn Wolfgang Schuller, Phuong N. Pham, Synho Do, Constantinos S. Pattichis and Pradeep Nair
O Chapter’s Title: Using Machine Learning to Predict Mortality for COVID-19 Patients on Day 0 in the ICU
O Publication: Frontiers in Digital Health, February 2022
O DOI: 10.3389/fdgth.2021.681608
O ISBN 978-2-88974-639-2
4. E-Book: AI-enabled Data Science for COVID-19,
Edited by Da Yan, Hong Qin, Hsiang-Yun Wu and Jake Y. Chen
O Chapter’s Title: Symptom Prediction and Mortality Risk Calculation for COVID-19
O Publication: Frontiers in Artificial Intelligence and Frontiers in Big Data. 22 June 2021
O DOI: 10.3389/frai.2021.673527
O ISBN 978-2-88974-050-5
5. Book: Interdisciplinary Cancer Research,
Edited by Professor Nima Rezaei
O Chapter’s Title:
Signalling Pathways in Neurological Cancers
O Publication: Springer, Cham, 2022 (publishing/ Gally proof)
O DOI: 10.1007/16833_2022_14
- Journal papers
10. Seddighi AS, Nikouei A, Seddighi A, Hosseini M, Hosseini M,
Zali A, Arjmand Y. A New Modified Video Solution System for Neuroendoscopic Procedures. Iranian Journal of Neurosurgery. 2022 Jan 10;8(1):2-. DOI:
10.32598/irjns.8.2
11. Alipour M, Motavaf M, Abdolmaleki P,
Zali A, Ashrafi F, Safari S, Hajipour-Verdom B. Structural Analysis and Conformational Dynamics of Short Helical Hyperphosphorylated Segments of Tau Protein (Sequence 254–290) in Alzheimer’s Disease: A Molecular Dynamics Simulation Study. Frontiers in Molecular Biosciences. 2022;9. doi: 10.3389/fmolb.2022.884705
12. Seddighi AS, Seddighi A, Ghadirian M,
Zali A, Far SM. Neuropathic pain: mechanism, representation, management and treatment. International Clinical Neuroscience Journal. 2022;9:e18-. doi:10.34172/icnj.2022.18
13. Saeedzadeh E,
Zali A, Nedaei H, Ganjaroodi SZ. Stereotactic iodine-125 brachytherapy for low grade glioma tumors treatment: A monte carlo study. International Clinical Neurosciences Journal. 2022;9:e9-. doi:10.34172/icnj.2022.09
14. Petoft A, Abbasi M,
Zali A. Toward children's cognitive development from the perspective of neurolaw: implications of Roper v Simmons. Psychiatry Psychology and Law. 2022;29(1).
https://doi.org/10.1080/13218719.2021.2003267
15. Khoshnood RJ,
Zali A, Tafreshinejad A, Ghajarzadeh M, Ebrahimi N, Safari S, et al. Correction to: Parkinson's disease and COVID‑19: a systematic review and meta‑analysis. Neurol Sci. 2022;43(2):1485. https://doi.org/10.1007/s10072-021-05781-3
16. Farahani M, Rezaei-Tavirani M,
Zali A, Zamanian-Azodi M. Systematic Analysis of Protein-Protein and Gene-Environment Interactions to Decipher the Cognitive Mechanisms of Autism Spectrum Disorder. Cell Mol Neurobiol. 2022 May;42(4):1091-1103.doi: 10.1007/s10571-020-00998-w
17. Jamshidi E, Asgary A, Tavakoli N,
Zali A, Setareh S, Esmaily H, et al. Using Machine Learning to Predict Mortality for COVID-19 Patients on Day 0 in the ICU. Frontiers in digital health. 2022; 3:681608. doi: 10.3389/fdgth.2021.681608
18. Dehghani L, Khojasteh A, Soleimani M, Oraee-Yazdani S, Keshel SH, Saadatnia M,
Zali A, et al. Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial. International Journal of Preventive Medicine. 2022;13(1):7. DOI: 10.4103/ijpvm.ijpvm_441_21
19. Akrami, F.,
Zali A. & Abbasi, M. An Islamic Bioethics Framework to Justify the At-risk Adolescents’ Regulations on Access to Key Reproductive Health Services. ABR 14, 225–235 (2022). https://doi.org/10.1007/s41649-021-00200-3
20. Sohrabi, MR., Amin, R., Maher, A. et al. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran. BMC Infect Dis 21, 474 (2021). https://doi.org/10.1186/s12879-021-06179-4
21. Eftekharian S,
Zali A, Roodsari SR, Pirmohamadi H, Arab-Mazar Z, Rahimi M. Pain Management Strategies and Improving Comfort in Orthodontics. Interventional Pain Medicine and Neuromodulation. 2021 Dec 31;1(1). DOI: 10.5812/ipmn.117324
22. Ghasemi Z, Safari S,
Zali A. Role of Pharmacoeconomics in Precision Medicine. Precision Medicine and Clinical OMICS. 2021 Dec 31;1(1). DOI: 10.5812/pmco.115774
23. Safari S,
Zali A, Akhlaghdoust M, Pezeshgi P. Iran’s Scientific Publications on Neuromodulation. Interventional Pain Medicine and Neuromodulation. 2021 Dec 31;1(1). DOI: 10.5812/ipmn.115244
24. Zali A, Joybari AY, Bayat M. Treatment of Brain Metastases; an Interdisciplinary Approach to a Conundrum. Precision Medicine and Clinical OMICS. 2021 Dec 31;1(1). DOI: 10.5812/pmco.115565
25. Seddighi AS, Rahimi Baghdashti H, Seddighi A, Hosseini M, Hosseini M,
Zali A, Jamshidi S. The Effects of Skill Lab Programs in Training of Neurosurgery Residents. Iranian Journal of Neurosurgery. 2021 Oct 10;7(4):179-84. DOI:
10.32598/irjns.7.4.2
26. Yazdani SO, Akhlaghpasand M, Golmohammadi M, Rostami F, Shokri G, Hafizi M, Oraee-Yazdani M,
Zali A, Soleimani M. Different Recurrence and Growth Pattern of Gliomatous Foci after Mesenchymal Stem Cell Harbouring the Herpes Simplex Thymidine Kinase Gene Transplantation in Multifocal Glioblastoma Multiform: A Clinical Case Report. 2021;
Research Square. DOI: https://doi.org/10.21203/rs.3.rs-556539/v1
27. Hashemi M, Zali A, Golmakani E, Delshad MH, Shadnoush M, Akbari ME. Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study. DARU Journal of Pharmaceutical Sciences. 2021; 29 (1): 51–59. doi: 10.1007/s40199-020-00381-6.
28. Vojdani S, Ghaderian SMH,
Zali A, Rakhshan A, Yazdani SO, Poursheikhani A, Bidari Zerehpoush F, Sharifi G.
Altered expression of EGFR and miR-34a derived from serum and tumoral tissue was associated with glioblastoma multiform. Experimental and Molecular Pathology. 2021; 104655. doi: 10.1016/j.yexmp.2021.104655. Epub 2021 May 29.
29. Oraee-Yazdani, S., Akhlaghpasand, M.,Zali A ,. Shokri, G. et al. Intracerebral Administration of Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle for Treatment of Glioblastoma Multiform: Safety and Feasibility Assessment. Mol Neurobiol 58, 4425–4436 (2021). https://doi.org/10.1007/s12035-021-02393-y
30. Lak A, Sharifi A, Badr S,
Zali A, Maher A, Mostafavi E, Khalili D. Spatio-temporal Patterns of the COVID-19 Pandemic, and Place-based Influential Factors at the Neighborhood scale in Tehran. Sustainable Cities and Society. 2021; 103034. DOI: 10.1016/j.scs.2021.103034
31. Nasiri R, Akbarpour S,
Zali A, Khodakarami N, Boochani MH, Noory AR, Soori H. Spatio-temporal analysis of COVID-19 incidence rate using GIS: a case study-Tehran metropolitan, Iran. GeoJournal. 2021; 1-15. doi: 10.1007/s10708-021-10438-x.
32. Safari S, Jahangirifard A,
Zali A, Salimi A, Bastanhagh E, Aminnejad R, Khoshnood R J, D Ommi.
Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 Patients. Pharmaceutical Sciences. 2021. doi: 10.34172/PS.2021.26
33. Besharat S, Rahimi F,
Zali A, Afaghi S, Esmaeili Tarki F, Pourmotahari F, et al. Chest CT Imaging Characteristics of COVID-19 Pneumonia in Surviving and Non-surviving Hospitalized Patients: A Retrospective Study in a Referral Center in Tehran, Iran. Iran J Radiol. 2021;18(2):e106339. doi: 10.5812/iranjradiol.106339.
34. Darazam IA, Shokouhi S, Pourhoseingholi MA, Irvani SSN, Mokhtari M, Shabani M, Amirdosara M, Torabinavid P, Golmohammadi M, Hashemi SP, Azimi A, Jafarazadeh Maivan MH, Rezaei O,
Zali A, Hajiesmaeili M, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, A Khoshkar.
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep 11, 8059 (2021). https://doi.org/10.1038/s41598-021-86859-y
35. Bahadori MB, Zengin G, skandaniM E,
Zali A, Sadoughi MM, Ayatollahi SA. Determination of phenolics composition, antioxidant activity, and therapeutic potential of Golden marguerite (Cota tinctoria). Food Measure 15, 3314–3322 (2021). https://doi.org/10.1007/s11694-021-00886-x
36. Khalooeifard R, Shariatpanahi ZV, Ahani A, Keykhaee M, Oraee-Yazdani M,
Zali A, Oraee-Yazdani S. Effect of Protein Supplement on Paraspinal Muscles in Spine Fusion Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. International Journal of Spine Surgery. 2021; 15 (1), 47-54. DOI: https://doi.org/10.14444/8005
37. Tavanaei R, Yazdani KO, Akhlaghpasand M,
Zali A, Oraee-Yazdani S. Changed pattern of hospital admission in stroke during COVID-19 pandemic period in Iran: a retrospective study. Neurol Sci 42, 445–453 (2021). https://doi.org/10.1007/s10072-020-05030-z
38. Tavanaei R, Oraee-Yazdani M, Allameh F, Eliaspour D,
Zali A, Oraee-Yazdani S. Cauda equina syndrome due to herpes simplex virus type 2-associated meningoradiculitis (Elsberg syndrome) after posterior lumbar spinal fusion surgery: Case report and review of literature. Clin Neurol Neurosurg. 2021; 205:106624. doi: 10.1016/j.clineuro.2021.106624.
39. Salari M, Etemadifar M,
Zali A, Medghalchi A, Tehrani Fateh S, Aminzade Z. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study. Mov Disord. 2021; 36 (4):
794-5. https://doi.org/10.1002/mds.28580
40. Saghafi A, Aghaali M, Saghafi H,
Zali A. Acute kidney injury in hospitalized COVID-19 patients in Iran; a systematic review and meta-analysis. J Renal Inj Prev. 2021; 10 (2):
1-10. doi: 10.34172/jrip.2021.09
41. Majidpoor J, Mortezaee K, Khezri Z, Fathi F,
Zali A, Derakhshan HB, Ghasemzadeh Bariki M, Joghataie MT, Shirazi R, Moradi F. The effect of the "segment" of spinal cord injury on the activity of the nucleotide-binding domain-like receptor protein 3 inflammasome and response to hormonal therapy. Cell Biochem Funct. 2021; 39 (2): 267-76. doi: 10.1002/cbf.3574
42. Khoshnood RJ, Ommi D,
Zali A, Ashrafi F, Vahidi M, Azhide A, et al. Epidemiological Characteristics, Clinical Features, and Outcome of COVID-19 Patients in Northern Tehran, Iran; a Cross-Sectional Study. Adv J Emerg Med. 2021; 5(1):
10. DOI: 10.22114/ajem.v0i0.547
43. Jalilian Khave L, Vahidi M, Shirini D, Sanadgol G, Ashrafi F, Arab-Ahmadi M,
Zali A, Ommi D, Nohesara S, Khoshnood RJ, Abdi S, Pirsalehi A, Masarat E, Shokoohi M, Karamouzian M. Clinical and Epidemiological Characteristics of Postdischarge Patients with COVID-19 in Tehran, Iran: Protocol for a Prospective Cohort Study (Tele-COVID-19 Study). JMIR Res Protoc. 2021; 10 (2): e23316. doi: 10.2196/23316
44. Hadei M, Mohebbi SR, Hopke PK, Shahsavani A, Bazzazpour S, Alipour M,
Zali A, Yarahmadi M, Farhadi M, Rahmatinia M, Hasanzadeh V, Hashemi Nazari SS, Asadzadeh-Aghdaei H, Tanhaei M, Zali MR, Kermani M, Vaziri MH, Chobineh H. Presence of SARS-CoV-2 in the air of public places and transportation. Atmos Pollut Res. 2021; 12 (3): 255-9. doi: 10.1016/j.apr.2020.12.016
45. Dehghani L, Hashemi SM, Saadatnia M,
Zali A, Oraee-Yazdani S, Heidari Keshel S, Khojasteh A, Soleimani M.
Correction to: Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review. Stem Cell Rev Rep. 2021; 17(2):428-38. doi: 10.1007/s12015-021-10153-7
46. Baghaei P, Dastan F, Marjani M, Moniri A, Abtahian Z, Ghadimi S,
Zali A, Velayati AA, Tabarsi P. Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021; 92:107329. doi: 10.1016/j.intimp.2020.107329
47. Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M,
Zali A, Hajiesmaeili MR, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, Khoshkar A. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep 11, 8059 (2021). https://doi.org/10.1038/s41598-021-86859-y
48. Lak A,
Zali A, Badr S, Mostafavi E, Baradaran HR, Hanani K, Toomanian A, Khalili D.
A description of spatial-temporal patterns of the novel COVID-19 outbreak in the neighbourhoods’ scale in Tehran, Iran. Medical Journal of the Islamic Republic of Iran (MJIRI). 2021; 35 (1): 954-961.doi:
10.47176/mjiri.35.128
49. Vahidi M, Shirini D, Sanadgol G, Ashrafi F, Arab-Ahmadi M, Fatemi A, Shabani M, Hassanzadeh T, Rezaei B,
Zali A, Ommi D, Nohesara S, Abdi S, Pirsalehi A, Masarat E, Shokoohi M, Karamouzian M.
A prospective cohort of clinical and epidemiological characteristics of COVID-19 patients post-discharge in Tehran, Iran (Tele-COVID-19): Research protocol and baseline findings. JMIR Research Protocols. 2021 Feb 2;10(2):e23316. doi: 10.2196/23316.
50. Ashrafi F, Ommi D, Zali A, Khani S, Soheili A, Arab-Ahmadi M, Behnam B, Nohesara S, Semnani F, Fatemi A, Salari M.
Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study. Archives of academic emergency medicine. 2021 Apr 27;9(1):e34. doi: 10.22037/aaem.v9i1.1210.
51. Salari M, Etemadifar M,
Zali A, Aminzade Z, Farsinejad P, Fateh ST. Covid-19 impact on Parkinson's Disease patients treated by drugs or deep brain stimulation.
Neurología. 2 August 2021,
https://doi.org/10.1016/j.nrl.2021.07.002
52. Jamshidi E, Asgary A, Tavakoli N,
Zali A, Dastan F, Daaee A, Badakhshan M, Esmaily H, Jamaldini SH, Safari S, Bastanhagh E, Maher A, Babajani A, Mehrazi M, Sendani Kashi MA, Jamshidi M, Sendani MH, Rahi SJ and Mansouri N (2021) Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning. Front. Artif. Intell. 4:673527. doi: 10.3389/frai.2021.673527
53. Golmohammadi M, Akhlaghpasand M, Oraee-Yazdani S,
Zali A. Effectiveness of autologous schwann cell and bone marrow-derived mesenchymal stem cell transplantation for individuals with spinal cord injury in promoting sensory recovery. International Clinical Neurosciences Journal. 2021; 8 (1): 9-13. doi:10.34172/icnj.2021.03
54. Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M,
Zali A, et al. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep 11, 8059 (2021). https://doi.org/10.1038/s41598-021-86859-y
55. Ebrahimpour A, Chehrassan M, Sadighi M, Azizmohammad Looha M, Karimi A, Raeisi A,
Zali A, et al. Mobile Spine Osseous Sarcoma: Descriptive Epidemiological Analysis Based on a National Population-Based Study. Archives of Iranian Medicine. 2021;24(8):629-35. doi: 10.34172/aim.2021.89
56. Hadei M, Hopke PK, Shahsavani A, Raeisi A, Jafari AJ, Yarahmadi M,
Zali A, et al. Effect of short-term exposure to air pollution on COVID-19 mortality and morbidity in Iranian cities. Journal of Environmental Health Science and Engineering. 2021 Oct 28;19(2):1807-1816. doi: 10.1007/s40201-021-00736-4.
57. Islam MT, Hossen M, Kamaz Z,
Zali A, Kumar M, Docea AO, et al. The role of hmgb1 in the immune response to sars-cov-2 infection: From pathogenesis towards a new potential therapeutic target. Farmacia. 2021;69(4):621-34. https://doi.org/10.31925/farmacia.2021.4.1
58. Khosravi Shadmani F, Amanollahi A,
Zali A, Najafi F, Karami M, Moradi G, et al. Description of Epidemiological Features, Symptoms and Mortality of the Patients with COVID-19 in Some Provinces of Iran. Arch Iran Med. 2021;24(10):733-40. doi: 10.34172/aim.2021.108
59. Oraee-Yazdani S, Akhlaghpasand M, Golmohammadi M, Hafizi M, Zomorrod MS, Kabir NM,
Zali A, et al. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes. Stem Cell Research and Therapy. 12, 445 (2021). https://doi.org/10.1186/s13287-021-02515-2
60. Pezeshgi P, Zali A, Safari S, Akhlaghdoust M, Marandi AS. Homocysteine levels and ischemic stroke: A systematic review. Journal of Cellular and Molecular Anesthesia. 2021;6(3):269-75.
https://doi.org/10.22037/jcma.v6i3.33877
61. Rajabi M, Ommi D, Zali A, Arefian NM. Effects of Dexmedetomidine On the Postoperative Shivering, Nausea, and Vomiting Among Opium User Patients Undergoing Elective Supratentorial Brain Tumor Surgery: A Randomized, Placebo, Controlled Clinical trials. Galen Medical Journal. 2021;10.
https://doi.org/10.31661/gmj.v10i0.2146
62. Safari S, Zali A, Pezeshgi P, Bastanhagh E, Jahangirifard A, Akhlaghdoust M. Neuroprotective strategies in the perioperative period: A systematic review. Journal of Cellular and Molecular Anesthesia. 2021;6(1):50-65. https://doi.org/10.22037/jcma.v6i1.33072
63. Salari M, Etemadifar M,
Zali A, Aminzade Z, Navalpotro-Gomez I, Tehrani Fateh S. Covid-19 in Parkinson's Disease treated by drugs or brain stimulation. Neurologia (Engl Ed). 2021. doi: 10.1016/j.nrl.2021.07.002
64. Samany NN, Toomanian A, Maher A, Hanani K,
Zali A. The most places at risk surrounding the COVID-19 treatment hospitals in an urban environment- case study: Tehran city. Land Use Policy. 2021;109.
65. Shafiee S, Zali A, Shafizad M, Emami Zeydi A, Ehteshami S, Rezaii F, et al. The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial. Ethiop J Health Sci. 2021;31(4):807-16. doi:10.4314/ejhs.v31i4.15
66. Tavanaei R, Ahmadi P, Yazdani KO,
Zali A, Oraee-Yazdani S. The Impact of the Coronavirus Disease 2019 Pandemic on Neurosurgical Practice and Feasibility of Safe Resumption of Elective Procedures During this Era in a Large Referral Center in Tehran, Iran: An Unmatched Case-Control Study. World Neurosurgery. 2021;154: e370-e81. doi: 10.1016/j.wneu.2021.07.047
67. Zali A, Khoshnood RJ, Motavaf M, Salimi A, Akhlaghdoust M, Safari S, et al. Deep brain stimulation for multiple sclerosis tremor: A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 2021 Nov;56:103256. doi: 10.1016/j.msard.2021.103256.
68. Zali A, Sohrabi MR, Mahdavi A, Khalili N, Taheri MS, Maher A, et al. Correlation Between Low-Dose Chest Computed Tomography and RT-PCR Results for the Diagnosis of COVID-19: A Report of 27,824 Cases in Tehran, Iran. Academic Radiology. 2021;28(12):1654-61.
https://doi.org/10.1016/j.acra.2020.09.003
69. Yazdani SO, Akhlaghpasand M, Golmohammadi M, Hafizi M, Zomorrod MS, Kabir NM, Yazdani MO,
Zali A, Soleimani M. Combining Cell Therapy with Autologous Schwann Cell and Bone Marrowderived Mesenchymal Stem Cell in Patients with Subacute Complete Spinal Cord Injury: Safety Considerations and Possible Outcomes. Stem Cell Res Ther. 2021 Aug 9;12(1):445. doi: 10.1186/s13287-021-02515-2
70. Hajimohammadebrahim-Ketabforoush M, Shahmohammadi MR,
Zali A, Shariatpanahi ZV. COVID-19-associated stroke risk: Could nutrition and dietary patterns have a contributing role? World Journal of Meta-Analysis.2020; 8 (6): 435-445. doi: 10.13105/wjma.v8.i6.435
71. Advani S, Zali A, Ommi D, Fatemi A, Khoshnoud RJ, Ashrafi F.
Transverse myelitis in COVID-19 patients: Report of two cases. Clinical Case Reports. 2021 Dec;9(12):e05196. https://doi.org/10.1002/ccr3.5196
72. Zali A, Gholamzadeh S, Mohammadi G, Azizmohammad Looha M, Akrami F, Zarean E, et al. Baseline Characteristics and Associated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran. Arch Acad Emerg Med. 2020; 8(1): e70. https://doi.org/10.22037/aaem.v8i1.872
73. Zali A, Ashrafi F, Ommi D, Behnam B, Arab-Ahmadi M. The Deadly Cost of Ignorance: The Risk of Second Wave of COVID-19. Asia-Pac J Public Health. 2020; 32(8):
511-2. doi: 10.1177/1010539520957809.
74. Yousefifard M, Zali A, Zarghi A, Madani Neishaboori A, Hosseini M, Safari S. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence. Int J Clin Pract. 2020; 74(9): e13557. doi: 10.1111/ijcp.13557
75. Yousefifard M, Zali A, Mohamed Ali K, Madani Neishaboori A, Zarghi A, Hosseini M, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med. 2020; 8(1): e45.
76. Yousefifard M, Ali KM, Aghaei A,
Zali A, Neishaboori AM, Zarghi A, et al. Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis. Iran J Public Health. 2020; 49(8):
1411-21. https://doi.org/10.18502/ijph.v49i8.3863
77. Shamsi-Gooshki E, Parsapoor A, Asghari F, Parsa M, Saeedinejad Y, Biroudian S,
Zali A, et al. Developing "Code of Ethics for Medical Professionals, Medical Council of Islamic Republic of Iran". Arch Iran Med. 2020; 23(10):
658-64. doi: 10.34172/aim.2020.83
78. Salimi A, Zali A, Seddighi AS, Seddighi A, Meshkat S, Hosseini M, et al. Descriptive Epidemiology of Brain and Central Nervous System Tumours: Results from Iran National Cancer Registry, 2010-2014. J Cancer Epidemiol. 2020; 2020: 10. https://doi.org/10.1155/2020/3534641
79. Salari M, Zali A, Ashrafi F, Etemadifar M, Sharma S, Hajizadeh N, et al. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic. Mov Disord. 2020; 35(7): <
No items yet!
Founder
24-Feb-10